For Indigenous Infants, RSV Prevention is Better Than a Cure
- Anna Banerji
Access Resources
About
This article discusses the importance of preventing respiratory syncytial virus (RSV) in Indigenous infants, particularly focusing on the high rates of RSV-related hospital admissions among Inuit infants in Canada's Nunavut territory. The author highlights the effectiveness of preventive therapy like palivizumab in reducing hospitalizations due to RSV but notes the cost barriers and limited access for at-risk infants. The article emphasizes the need to expand preventive therapy to include all Inuit babies, despite the expense, due to the high risks faced by infants in remote communities. It also addresses broader health disparities faced by Indigenous populations in Canada and other countries, advocating for action to address these inequalities.
Tags
More like this
The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.